Recent advances in targeted drug delivery systems for resistant colorectal cancer

Colorectal cancer (CRC) is one of the deadliest cancers in the world, the incidences and morality rate are rising and poses an important threat to the public health. It is known that multiple drug resistance (MDR) is one of the major obstacles in CRC treatment. Tumor microenvironment plus genomic in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharifi-Azad, Masoumeh, Fathi, Marziyeh, Cho, William C., Barzegari, Abolfazl, Dadashi, Hamed, Dadashpour, Mehdi, Jahanban-Esfahlan, Rana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117978/
https://www.ncbi.nlm.nih.gov/pubmed/35590367
http://dx.doi.org/10.1186/s12935-022-02605-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117978/
https://www.ncbi.nlm.nih.gov/pubmed/35590367
http://dx.doi.org/10.1186/s12935-022-02605-y

Ejemplares similares